INSERM - UMR866 - Centre de recherche

Dr Lloyd Bod

Institution : Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women’s Hospital , Boston

Topic : Tumor-infiltrating B cells: Friends or Foes?

Date : 0000-00-00

Locality : UFR Science de Santé Salle R17 - 27/11/2019 de 11 à 12h30
Dr Alexandre Reymond

Institution : Centre intégratif de Génomique, UNIL , Lausanne

Topic : Architecture du génome et maladies : Le paradigme 16q11.2

Date : 2019-12-10

Locality : CHU Dijon - Salle des évènements (5ème étage - Hall B)

Les dernières publications du laboratoire

Intensive Care Med : Use of combined cardiac and lung ultrasound to predict weaning failure in elderly, high-risk cardiac patients: a pilot study.
Auteur(s) : Bouhemad B, Mojoli F, Nowobilski N, Hussain A, Rouquette I, Guinot PG, Mongodi S
Nat Commun : Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance.
Auteur(s) : Cotte AK, Aires V, Fredon M, Limagne E, Derangère V, Thibaudin M, Humblin E, Scagliarini A, de Barros JP, Hillon P, Ghiringhelli F, Delmas D
Blood : HSP110 sustains chronic NF-κB signaling in activated B cell diffuse large B cell lymphoma through MyD88 stabilization.
Auteur(s) : Boudesco C, Verhoeyen E, Martin L, Chassagne-Clement C, Salmi L, Mhaidly R, Pangault C, Fest T, Ramla S, Jardin F, Wolz OO, Weber ANR, Garrido C, Jego G

"Lipids, Nutrition, Cancer" LNC

The INSERM Research Centre UMR866 ‘Lipids, Nutrition, Cancer - LNC’ was created the 1st of January 2007 and gathers several laboratories from the Université de Bourgogne, the INSERM, the EPHE et AgroSup.

The overall vocation of INSERM UMR866 is to promote fundamental and clinical research in the fields of cancer, nutrition, lipid biology, and cardiometabolic risk. Over the last years, and beyond common administration of UMR866, one main duty was to favour interactions between distinct subgroups in order :

to increase the cohesion
to set up and extend common facilities
to support translational research and joined programs involving several UMR866 teams as well as clinical departments of the University Hospital and the CGFL anti-cancer center,
to welcome new/additional groups coming from both the University of Burgundy and outside
to create a well-identified specificity at the interface of cancer biology and metabolic disease.

There are actually 8 teams and 2 associated teams inside UMR866

Current configuration of UMR866

On January 1st 2007, INSERM Research Center included 9 distinct groups, involving 211 persons (researchers + teaching-researchers + technicians/engineers + postdocs + PhD students). Four teams were involved in cancer biology, one in cancer epidemiology, and four in lipids and nutrition. Teams were as follows:

The current configuration of the Research center UMR866-LNC gathers more than 200 researchers, teachers-researchers (including forty doctors), Engineers, Technicians, Post-Docs, PhD students and Students distributed in 8 teams: